Foot-and-mouth disease virus 3C protein acts as an anti-inflammatory factor by mediating degradation of TLR4 signaling various molecules via caspase activity
Jing Zhang , Yuan Wen , Jiamin Yi , Jingjing Ren , Weiwei Li , Junhuang Wu , Wenping Yang , Dan Li , Haixue Zheng
{"title":"Foot-and-mouth disease virus 3C protein acts as an anti-inflammatory factor by mediating degradation of TLR4 signaling various molecules via caspase activity","authors":"Jing Zhang , Yuan Wen , Jiamin Yi , Jingjing Ren , Weiwei Li , Junhuang Wu , Wenping Yang , Dan Li , Haixue Zheng","doi":"10.1016/j.vetmic.2025.110531","DOIUrl":null,"url":null,"abstract":"<div><div>During the early stages of foot-and-mouth disease virus (FMDV) infection, a series of acute inflammatory responses occur in the host. As the disease progresses, these inflammatory responses gradually weaken until the host is nearly recovered. However, the mechanism by which FMDV participates in the negative regulation of host inflammatory responses remains unclear. In this study, we found that FMDV 3C plays a crucial role in inhibiting the inflammatory response by degrading various molecules in the TLR4 signaling pathway. Mechanistically, we discovered that this degradation is mediated by caspase activity, which is activated by 3C protease. Specifically, FMDV 3C targets TLR4, TRIF, p65, IRF3, and TBK1 for degradation through caspase-3, and degrades IRF3 and TBK1 via caspase-8. Notably, FMDV 3C targets TBK1 for degradation through caspase-3, caspase-8, and caspase-9 independently. In conclusion, this is the first report identifying FMDV 3C as an anti-inflammatory factor that mediates the degradation of various molecules to inhibit TLR4 signaling through caspase activity. This study provides a novel insight into explore the relationship between FMDV and inflammation and offers ideas for exploring the biological function of 3C and the pathogenesis of FMDV.</div></div>","PeriodicalId":23551,"journal":{"name":"Veterinary microbiology","volume":"305 ","pages":"Article 110531"},"PeriodicalIF":2.4000,"publicationDate":"2025-04-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Veterinary microbiology","FirstCategoryId":"97","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S037811352500166X","RegionNum":2,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
During the early stages of foot-and-mouth disease virus (FMDV) infection, a series of acute inflammatory responses occur in the host. As the disease progresses, these inflammatory responses gradually weaken until the host is nearly recovered. However, the mechanism by which FMDV participates in the negative regulation of host inflammatory responses remains unclear. In this study, we found that FMDV 3C plays a crucial role in inhibiting the inflammatory response by degrading various molecules in the TLR4 signaling pathway. Mechanistically, we discovered that this degradation is mediated by caspase activity, which is activated by 3C protease. Specifically, FMDV 3C targets TLR4, TRIF, p65, IRF3, and TBK1 for degradation through caspase-3, and degrades IRF3 and TBK1 via caspase-8. Notably, FMDV 3C targets TBK1 for degradation through caspase-3, caspase-8, and caspase-9 independently. In conclusion, this is the first report identifying FMDV 3C as an anti-inflammatory factor that mediates the degradation of various molecules to inhibit TLR4 signaling through caspase activity. This study provides a novel insight into explore the relationship between FMDV and inflammation and offers ideas for exploring the biological function of 3C and the pathogenesis of FMDV.
期刊介绍:
Veterinary Microbiology is concerned with microbial (bacterial, fungal, viral) diseases of domesticated vertebrate animals (livestock, companion animals, fur-bearing animals, game, poultry, fish) that supply food, other useful products or companionship. In addition, Microbial diseases of wild animals living in captivity, or as members of the feral fauna will also be considered if the infections are of interest because of their interrelation with humans (zoonoses) and/or domestic animals. Studies of antimicrobial resistance are also included, provided that the results represent a substantial advance in knowledge. Authors are strongly encouraged to read - prior to submission - the Editorials (''Scope or cope'' and ''Scope or cope II'') published previously in the journal. The Editors reserve the right to suggest submission to another journal for those papers which they feel would be more appropriate for consideration by that journal.
Original research papers of high quality and novelty on aspects of control, host response, molecular biology, pathogenesis, prevention, and treatment of microbial diseases of animals are published. Papers dealing primarily with immunology, epidemiology, molecular biology and antiviral or microbial agents will only be considered if they demonstrate a clear impact on a disease. Papers focusing solely on diagnostic techniques (such as another PCR protocol or ELISA) will not be published - focus should be on a microorganism and not on a particular technique. Papers only reporting microbial sequences, transcriptomics data, or proteomics data will not be considered unless the results represent a substantial advance in knowledge.
Drug trial papers will be considered if they have general application or significance. Papers on the identification of microorganisms will also be considered, but detailed taxonomic studies do not fall within the scope of the journal. Case reports will not be published, unless they have general application or contain novel aspects. Papers of geographically limited interest, which repeat what had been established elsewhere will not be considered. The readership of the journal is global.